-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Regulus Therapeutics Inc. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Regulus Therapeutics Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was $0.000.
- Regulus Therapeutics Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was $0.000.
- Regulus Therapeutics Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)